FDA WARNING_LETTER - Longford Water Company LLC - March 18, 2025

The U.S. Food and Drug Administration (FDA) issued a Warning Letter to Longford Water Company LLC on November 13, 2025, following an inspection conducted from March 17-18, 2025, at their bottled water facility in Longford, KS. The inspection revealed significant violations of the Processing and Bottling of Bottled Drinking Water Regulations (21 CFR Part 129), rendering the company R

s bottled water products adulterated.

Key issues identified included the company R

s failure to ensure the effectiveness of its water treatment process, specifically for water sanitation, lacking data to support its purpose and records of performance and effectiveness. Longford Water also failed to conduct weekly bacteriological testing for each type of bottled drinking water produced, neglecting to sample all product types and properly dechlorinate samples. Furthermore, the company did not conduct required quarterly sampling and inspection of containers and closures for contamination. Lastly, violations were noted for inadequate cleaning and sanitization of product water-contact surfaces, with incomplete records and insufficient treatment details.

The FDA requires Longford Water Company LLC to provide a written response within 15 working days, detailing specific corrective actions taken to address these violations, including steps to prevent recurrence and supporting documentation. Failure to adequately address these concerns may lead to further legal or administrative action.